Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 18, 2023
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term
Big gains in bone marrow transplant survival since mid-2000s
Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
Remembering Dr. Ron Reeder, molecular biologist-turned-photographer
Renaissance man and expert in gene regulation had enduring impact on Fred Hutch’s Basic Sciences Division
Three's a charm in a triple-drug combination for transplant patients
A drug with a storied past offers a new edge against an old foe
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
Good News at Fred Hutch: Immunotherapy pioneer named chair, Nobel laureate keynotes
Celebrating faculty and staff achievements
A life in tune
Erlinda Santos balances science and song after more than four decades at Fred Hutch
From building toys to developing cures
At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles
Good News at Fred Hutch
<p>Dr. Rainer Storb receives $12.9M to study blood stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design</p>
Lifesaving lessons from leukemia
Mini-transplant regimen may offer new hope for treatment of advanced kidney cancer